Home
Home » companies

Bristol-Myers Squibb

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial

Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial
Seeking Alpha

Gilead-Bristol Hepatitis C Drug Combo Cures All in Study

Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study

Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study
Bloomberg

4 Pharmaceutical Stocks to Buy Now

4 Pharmaceutical Stocks to Buy Now
InvestorPlace

Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue

Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue
Seeking Alpha

The 3 Drivers Behind The Big Pharma Rally

The 3 Drivers Behind The Big Pharma Rally
Seeking Alpha

Bristol profit drops sharply, but meets Wall Street forecast

Bristol profit drops sharply, but meets Wall Street forecast
Reuters

Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race

Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com

Bristol-Myers Hepatitis C Combo Therapy Blunts Disease

Bristol-Myers Hepatitis C Combo Therapy Blunts Disease
Bloomberg

Merck, Bristol-Myers will test hepatitis C regimen

Merck, Bristol-Myers will test hepatitis C regimen
Yahoo/AP